Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
This study has been completed.
Study NCT00399529
Information provided by Sidney Kimmel Comprehensive Cancer Center
First Received on November 13, 2006.
Last Updated on December 11, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
